It was, indeed, blue horseshoe. 'In the movie "Wall Street" (1987) the line, "Blue Horseshoe loves Anacott Steel," was the code that Gordon Gekko (Michael Douglas) had Bud Fox (Charlie Sheen) use for insider trading.' Good movie, by the way.
I thought people here might be interested in this:
https://www.msn.com/en-gb/money/other/british-miner-teams-up-with-company-backed-by-bill-gates-jeff-bezos-and-warren-buffett-to-hunt-down-mega-deposit-of-metals-used-in-electric-cars/ar-AAN5bG2?li=BBoPWjQ
Apologies if this is old news, but it sounds bullish to me. Regards.
Hell, yeah! In it to win it!
Lo, and behold, 600,000 shares at 6p appears as "unknown". Can anyone confirm buy or sell? Feels like a bargain buy but I could be wrong. Anyone?
You got a good price, Steve. 6p feels like bargain basement time. Experience tells me that when frustration and despair are at their most extreme, things usually start to turn around. The mms have had a grand old time walking this down on, frankly, tiny volume. Was it yesterday we were down over 3% on around 600,000 shares traded. That to me smells of manipulation in order to weed out the weak holders. Definitely a hold for me - even a buy at these levels, but the no news situation is not good news for the sp, sadly.
It's claimed that patience is a virtue, but this share would test the patience of a saint! Jeez. Let's hope the wait for news will be worth it. I'm sure it will be, just got to keep the faith. All best.
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
I haven't seen this posted before so apologies if this is old news. It would be amazing to see SDC-1801 on the list! Interestingly, baricitinib (which we at least equalled in pre-clinical trials, and possibly with little or no toxicity) is at the top of the list.
https://www.globaltimes.cn/page/202107/1229310.shtml
https://www.datenna.com/2015/02/20/p4-level-biosafety-lab-in-wuhan-first-in-asia/
The coincidence that Wuhan appears to have been the epicenter of the outbreak of the Covid pandemic, and the existence of a P4 biosafety lab in Wuhan, seems to me to be too striking to ignore, doesn't anyone think?
My thoughts exactly, Krone. The problem may well be that things in the UK (as of now) seem to be improving, and thus the urgency to back therapeutics has wained somewhat. But in my neck of the woods, things are out of control (partly because of a pitifully slow roll out of vaccines). Even in China (where many have been vaccinated) we are seeing a worrying resurgence of cases. It's important that the UK government don't take their eye off the ball, in other words. But a month after an amazing RNS from Sareum (re: SDC-1801 outperforming Dexamethasone), we are still awaiting a decision on Agile. Why?
Great post, as always. Recommended. It's surely only a matter of time before we hear news re: Agile/licensing deal(s)/full takeover? Good luck all, and, by the way, thanks to all the well-informed contributors to this forum. Your research and knowledge is greatly appreciated.
Having a jog? More like limbering up for the high jump!
The Bill and Melinda Gates Foundation has already contributed to the Agile programme, and Sareum would certainly fit the profile. https://www.therapeuticsaccelerator.org
If one scrolls down to "Explore investments made", we find this:
"Mild Disease Treatment
AGILE – University of Liverpool
Phase I/II trial using the most modern and innovative statistical methods allowing for multiple drugs to be tested in parallel, and to remove or add treatments faster than ever before, based on results of safety and efficacy."
James, not sure what your beef is, but cobaltblue has been here at least as long as I have (roughly 7 years) so I don't think he's a de-ramper. I think he was playing devil's advocate with some of his recent postings. I also think we should remember this is AIM and things can turn sour quickly. There's been a lot of talk about parties, pound land, luxury yachts/cars/villas, champagne and skittles, as if success is merely a matter of time. I'm hoping for a similar outcome, don't get me wrong, but a certain caution should be respected. And before anyone likens me to a SW19 resident, I have held for 7 years and will hold until the end. Over and out.
Apologies if already posted.
"Encouraging results from a Phase 1 study suggests some patients with advanced brain cancer who are EB1-positive could benefit from the first-ever targeted brain cancer treatment". Reference is made to the following article:
https://www.icr.ac.uk/news-archive/early-promise-for-first-targeted-brain-cancer-treatment
Cutting edge stuff and PYC is in the vanguard with its virtual tumor technology. Exciting times ahead. GLA.
Fair enough, Steve. I guess we all want our share investments to go stratospheric in record time, but that just simply never happens (at least not for me). SAR is a good example. I first bought in there at 0.9p 7 years ago, and watched my investment go down to 0.25p. I was gutted, but held on. Today it's around the 7p mark. Basically, you have to take the rough with the smooth and be ever patient. There's too much 'short-termism' (if that's a word) in the psyche of PIs these days - they want their profit and they want it NOW!! I really believe in PYC and think it will come good in the end. The daily ups and downs are really irrelevant if your target price is many multiples of today's SP. Anyway, all best with your future trades (especially with SAR, in which we both have a stake!).
Steve, did you by any chance go onto the Sareum or Corcel boards (both down well over 3% today) to express your disappointment, or was it just this board you thought you would try to unnerve with your negativity? Need I say more???????
Aber, indeed. Par for the course, I'm afraid. Still, if one is holding for 30p/40p/etc., these day-to-day gyrations are meaningless in the grand scheme of things. The mms will try to weaken our resolve, but when you've held for years, days/weeks are irrelevant. GLA.
It would tickle me less to know that the said transaction had cost me almost 1,000 shares. Daylight robbery.
Ahfam, good post (as always).
Just a minor correction. The Kymab/Sanofi deal was for $1.45 billion (not GBP).
https://www.globenewswire.com/news-release/2021/01/11/2155914/0/en/Sanofi-to-acquire-Kymab-adding-KY1005-to-its-pipeline-a-human-monoclonal-antibody-targeting-key-immune-system-regulator-OX40L.html
"Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have entered into an agreement under which Sanofi will acquire Kymab for an upfront payment of approximately $1.1 billion and up to $350 million upon achievement of certain milestones." Just wanted to clarify for the sake of accuracy. We're still talking big numbers, though!
So, yesterday, there was a sell at 6.50p for 230,930 shares. I was surprised that the price hardly moved at the time, until later when the MMs chose to drop the bid quite considerably. It was made to appear that the sizeable sell was somehow a precursor to a large exodus. Then, today, a sizable buy (230,607 at 6.50p) appears. It looks for all the world like a 'bed and isa' (albeit a day later) but made to look like someone divesting shares. All of these shenanigans points to one thing - a rerate is imminent. I may be wrong, but I've seen it many times before. My advice - fwiw - is don't be fooled into selling. The game's afoot and we're in play.